¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-2ÀÏ : 2024-03-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-2ÀÏ : 2024-03-29
±³À°ÀÏÀÚ : 2024-03-29
±³À°Àå¼Ò : ±×·£µå¿öÄ¿ÈúÈ£ÅÚ

±³À°ÁÖÁ¦ : 2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-2ÀÏ

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581  

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú

Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 35ºÐ

¼¼ºÎ¼ö°­·á : 300,000¿ø  

ºñ°í 2¿ù 28ÀϱîÁö  ȸ¿ø 100,000¿ø / ºñȸ¿ø 200,000¿ø3¿ù 1ÀϺÎÅÍ    ȸ¿ø  200,000¿ø / ºñȸ¿ø 300,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 09:00~09:25 The impact of immune profiling of T-cell and plasma cells on non-cellular immune therapy in myeloma Nizar J Bahlis(University of Calgary Canada)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 09:25~09:50 Single-cell techniques to characterize immune microenvironment in MM(multiple myeloma) Niels Weinhold(Univ Hosp Heidelberg Gemany)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 09:50~10:15 The power of ONE: Immunology in the age of single cell genomics Ido Amit(Weizmann Institute of Science Israel)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 10:30~11:15 How to win: Competitive strategies in the hematopoietic stem cell niche Margaret Goodell(Baylor College of Medicine USA)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 11:15~12:00 Factors Effect Quality Of Life Childhood Acute Lymphoblastic Leukemia Patients In Indonesia Ferza Alfath(Universitas Andalas Indonesia)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 12:15~13:05 Optimizing tolerability with asciminib in CML patients for better patient outcomes Qian Jiang(Peking University China)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 13:20~14:50 Clinical outcomes of TPO-receptor agonists in patients with steroid-refractory immune thrombocytopenia; Significant conditions of discontinuation with good response Jae-Ho Yoon(The Catholic University of Korea)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM2 15:05~15:30 Palliative care for patients with leukemia Min Sun Kim(Seoul National University Korea)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM2 15:30~15:55 Long-term survivorship in hematologic malignancies Shahrukh K. Hashmi(Mayo Clinic USA)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM2 15:55~16:20 The importance of monitoring symptoms and quality of life in routine hematology practice Fabio Efficace(Italian Group for Adult Hematologic Diseases Italy)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 16:35~17:00 Back to the basic: coagulation pathway Seonyang Park(Inje University Korea)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 17:00~17:25 Pharmacology: Anticoagulants and reversal agents Seo-Yeon Ahn(Chonnam National University Korea)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 17:25~17:50 Proper application of anticoagulation therapy on CAT Ho-Young Yhim(Jeonbuk National University Korea)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-2ÀÏ : 2024-03-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãá°èÇмú´ëȸ : 2024-03-29
´ÙÀ½±Û 2024³â ´ëÇѹé½ÅÇÐȸ Á¦23Â÷ Ãá°èÇмú´ëȸ : 2024-03-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20640 ¼­¿ï ´ëÇÑÀçÈ°ÀÇÇаúÀÇ»çȸ Stanley Lam ¿öÅ©¼¥ : 2024-05-19 0 43 2024-05-10
20639 ¼­¿ï Á¦40ȸ ´ëÇѳëÀÎÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 38 2024-05-10
20638 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2024³âµµ ¿¬¼ö°­Á : 2024-05-18 0 25 2024-05-10
20637 ÀÎõ 2024³âµµ Á¦47Â÷ ´ëÇѺ¹ºÎ¿µ»óÀÇÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-05-18 0 14 2024-05-10
20636 Àü³² 2024 Á¦2Â÷ ´ëÇѾȰúÀÇ»çȸ ½ÉÆ÷Áö¿ò : 2024-05-18 0 8 2024-05-10
20635 ¼­¿ï ´ëÇÑÇǺκ´¸®ÇÐȸ Á¦22ȸ ÇǺκ´¸® ½ÉÆ÷Áö¿ò : 2024-05-18 0 62 2024-05-10
20634 ´ëÀü 2024³â ´ëÀü±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 56 2024-05-10
20633 ¼­¿ï ´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18 0 55 2024-05-10
20632 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Á¦ 22Â÷ Ãá°èÁ¤±â½ÉÆ÷Áö¾ö ¹× ÃÑȸ : 2024-05-17 0 11 2024-05-10
20631 ÀÎõ 2024³âµµ Á¦47Â÷ ´ëÇѺ¹ºÎ¿µ»óÀÇÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2024-05-17 0 19 2024-05-10
20630 ºÎ»ê Á¦28Â÷ ¾Æ½Ã¾Æ-¿À¼¼¾Æ´Ï¾Æ »êºÎÀΰú¿¬¸Í Çмú´ëȸ (AOFOG 2024) (1ÀÏÂ÷) : 2024-05-17 0 14 2024-05-10
20629 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ¿Â¶óÀÎ_¼­¿ï°æÀÎÁöȸ 276Â÷ ¿ù·ÊÁý´ãȸ : 2024-05-17 0 18 2024-05-10
20628 ¼­¿ï 2024³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-17 0 20 2024-05-10
20627 ´ëÀü ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ´ëÀüÁöȸ ¿¬¼ö±³À° : 2024-05-17 0 28 2024-05-10
20626 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-05-13 0 20 2024-05-10
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷